%20(1).webp)

In the UK, nurse and pharmacist independent prescribers can legally prescribe ADHD medicines, including Schedule 2 stimulants, but only within their competence. NICE NG87 says ADHD medication should only be started by someone with training and expertise in diagnosing and managing ADHD, so prescribers need ADHD-specific CPD in titration, monitoring and shared care, plus supervised practice.
At Global ADHD Network, we train nurses, pharmacists and doctors who want to build safe ADHD prescribing practice. This guide sets out what UK regulators and NICE expect, what good ADHD training for non-medical prescribers includes, and how to choose a course. One point up front: a CPD course is not a prescribing qualification. It builds the competence you need to use the prescribing rights you already hold.
For the full career route, including registration, supervised experience, indemnity and where to work, read our guide on how to become an ADHD assessor in the UK.
This article is educational information for clinicians. It is not clinical advice, and it does not cover doses, drug choice or any individual patient.
It depends on your profession and your type of prescriber annotation. Nurse and pharmacist independent prescribers can, within competence. Most allied health professional independent prescribers cannot prescribe ADHD stimulants.
The Royal College of Nursing explains that nurse independent prescribers who have completed an NMC-approved prescribing programme (formerly referred to as V300) may prescribe any medicine, including controlled drugs in Schedules 2 to 5 and unlicensed medicines, provided this is within their scope of competence. Changes to the Misuse of Drugs Regulations in April 2012 allowed nurse independent prescribers to prescribe controlled drugs in Schedules 2 to 5, except cocaine, diamorphine and dipipanone for the treatment of addiction. The RCN notes that equivalent amendments in Northern Ireland, in May 2012, covered both nurse and pharmacist independent prescribers.
Pharmacists become independent prescribers by completing a programme accredited by the General Pharmaceutical Council, which then adds an annotation to their register entry. The GPhC describes a pharmacist independent prescriber as someone who can assess patients, make clinical decisions and prescribe "within their scope of practice". For the pharmacist angle in more depth, read our guide to ADHD training for pharmacists.
The HCPC states that independent prescribers "cannot prescribe controlled drugs unless extra laws have been passed which allow their profession to do so". Chiropodist or podiatrist, paramedic, physiotherapist and therapeutic radiographer independent prescribers may prescribe from a limited list of named controlled drugs. ADHD stimulants do not appear on the lists the HCPC publishes. If you are an AHP prescriber with an interest in ADHD, chat with your employer and professional body about where your role fits in an ADHD service.
Supplementary prescribing is a voluntary partnership between an independent prescriber, a supplementary prescriber and the patient, working to an agreed, patient-specific clinical management plan. The HCPC says supplementary prescribers "can prescribe controlled drugs, but only in accordance with a service user's clinical management plan". Some ADHD services use this model while a clinician builds experience.
The NMC says that professionals working in designated physician associate roles "should not prescribe medicines, even if they hold prescribing rights from a previous profession".
In short: work within your competence, follow the prescribing competency framework, and make sure you have ADHD-specific training and expertise before you initiate medication.
NICE guideline NG87, recommendation 1.7.2, says: "All medication for ADHD should only be initiated by a healthcare professional with training and expertise in diagnosing and managing ADHD." Recommendation 1.1.8 says mental health professionals "should undertake training so that they are able to diagnose ADHD and provide treatment and management in accordance with this guideline". NICE quality standard QS39, statement 6, covers starting drug treatment.
The NMC expects nurse and midwife prescribers to adhere to the Competency Framework for all Prescribers, now published by the Royal College of Pharmacy (formerly the Royal Pharmaceutical Society). The framework has ten competencies across two domains, the consultation and prescribing governance. Competency 7.1 asks prescribers to prescribe "within own scope of practice" and to recognise "the limits of own knowledge and skill". The framework also lists supervision, observation of practice and case-based discussions as tools for improving prescribing practice.
The framework defines scope of practice as activities you have the training, knowledge, skills and experience to deliver lawfully, safely and effectively, with appropriate indemnity cover for your prescribing role. Before you add ADHD to your scope, check your employer's governance and your indemnity provider's position.
Good ADHD training for non-medical prescribers turns general prescribing competence into ADHD-specific competence. It should be guideline-aligned, clinician-led and honest about its limits.
At a high level, training should cover:
These themes mirror the modules of Global ADHD Network's ADHD Management course, a CPD-accredited remote programme for qualified clinicians that covers adults and children and young people. Training covers principles and governance. It should never replace your own clinical judgement, your employer's protocols or the product information for any medicine.
Titration is where ADHD prescribing is most demanding, so training should focus on how to run it safely and record it well.
NICE NG87 recommendation 1.7.26 says that during titration, ADHD symptoms, impairment and adverse effects should be recorded at baseline and at each dose change on standard scales, with progress reviewed regularly with a specialist. Recommendation 1.7.27 says to titrate in line with the BNF or BNF for Children, and recommendation 1.8.1 asks clinicians to monitor effectiveness and adverse effects and document them in the person's notes.
For a non-medical prescriber, that means understanding the protocol your service uses, how review points are documented and who you escalate to. Our guide to what an adult ADHD titration protocol should include covers protocol design in more detail.
Many nurses and pharmacists first meet ADHD prescribing through shared care, when a specialist service hands on prescribing and monitoring after titration.
A shared care agreement sets out who is responsible for what, and the prescriber who signs a prescription remains accountable for it. The Competency Framework for all Prescribers specifically mentions prescribing under a shared care protocol or agreement. Read our complete guide to shared care and our post on shared care agreements for ADHD medication.
The final report of the independent ADHD Taskforce, published by NHS England, says post-diagnostic management, prescribing and follow-up for many people "can be provided by specialist nurses and pharmacists (for prescribing)", and recommends that interested primary care practitioners, including pharmacists, should have the opportunity to train in more specialist aspects of ADHD care such as prescribing. It also asks NHS England and DHSC to work with NICE to define what is meant by an appropriately ADHD qualified healthcare professional. Our summary of the ADHD Taskforce report for clinicians explains what it could mean for nurses, pharmacists and GPs, and our guide to ADHD training for GPs and primary care clinicians covers the primary care side.
NICE links initiating ADHD medication with expertise in diagnosing and managing ADHD. That is why many prescribers train in both.
A typical Global ADHD Network pathway looks like this:
Training alone is not the whole picture. The Royal College of Psychiatrists' report CR235, ADHD in adults: good practice guidelines (2023), written for general psychiatrists in Scotland, points to online CPD and national training courses, then adds: "this does not negate the need for locally organised clinical training and opportunities for supervision". We agree. At Global ADHD Network, we are clear that a CPD course builds competence but is not a licence to prescribe or diagnose independently. Your prescribing rights come from your regulator. Your scope comes from training, supervised experience and employer governance. If you are a nurse, our post on ADHD assessor training for nurses and the ADHD and autism assessor training pathway show how these steps fit together.
Choose a course that is built for qualified prescribers and is honest about what it does and does not give you.
Look for a course that is:
Our courses are clinician-led, CPD accredited and built around UK guidance, with a clear pathway from diagnosis to management to observership. For more on weighing up options, read how to choose an ADHD assessment course.
Nurse independent prescribers can prescribe any medicine within their scope of competence, including Schedule 2 to 5 controlled drugs, according to the Royal College of Nursing. That covers ADHD medicines in law, but NICE NG87 says ADHD medication should only be initiated by a healthcare professional with training and expertise in diagnosing and managing ADHD, so ADHD-specific training, supervision and employer governance still matter.
No. Prescribing rights come from completing an approved prescribing programme and having your prescriber status annotated by your regulator, such as the NMC, GPhC or HCPC. A CPD course, including Global ADHD Network's ADHD Management course, builds knowledge and competence. It is not a prescribing qualification.
To prescribe as a nurse, you need to complete an NMC-approved prescribing programme, formerly known as V300, and be registered as a prescriber. You can take ADHD CPD before or alongside that for knowledge, but you cannot prescribe until your prescriber status is on the register.
The HCPC says independent prescribers in these professions may only prescribe controlled drugs from a limited, named list, and ADHD stimulants are not on the lists it publishes. Supplementary prescribers can prescribe controlled drugs, but only in line with a patient's clinical management plan.
Yes. The live course page describes the ADHD Management course as a CPD-accredited, remote programme for qualified clinicians, framed for UK practice including NICE NG87 and NICE quality standard QS39. Check the course page for current details and dates.
The NMC says prescribing at a distance carries different opportunities and risks to face-to-face prescribing, and it asks nurse and midwife prescribers to consider its remote prescribing information. Follow your regulator's guidance and your employer's governance. This article does not give advice on any individual medicine or patient.
Explore Global ADHD Network's ADHD Management course and upcoming dates at globaladhdnetwork.com/courses, or email info@globaladhdnetwork.com to chat about the right pathway for your role.
